1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow TGCT: new trials by email Literature Review of TGCT trials Research Report on TGCT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) Emactuzumab, Placebo - TGCT | Phase 3 | Active not recruiting | SynOx Therapeutics Limited | 128 | 2024-10-09 | 2026-07-29 |
Synovitis (1) · Synovitis, Pigmented Villonodular (1)
Giant Cell Tumor of Tendon Sheath (1) · Giant Cell Tumors (1) · Joint Diseases (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Tendinopathy (1)
emactuzumab (1)
SynOx Therapeutics Limited (1)
Belgium (1) · Canada (1) · France (1) · Italy (1) · Netherlands (1) · South Korea (1) · Spain (1) · Sweden (1) · Switzerland (1) · Taiwan (1) · United Kingdom (1) · United States (1)